Pharmaceutical Equivalence by Design for Generic Drugs: Modified-Release Products

Author： Raw André   Lionberger Robert   Yu Lawrence  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.28, Iss.7, 2011-07, pp. : 1445-1453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmaceutical Policy regarding Generic Drugs in Belgium

By Simoens Steven  

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 755-766

Adis International

Access to resources Recommend Favorite

Fabrication and evaluation of captopril modified-release oral formulation

By Gohel Mukesh   Nagori Stavan Arunkumar  

Pharmaceutical Development and Technology, Vol. 14, Iss. 6, 2009-12 ,pp. : 679-686

Informa Healthcare

Access to resources Recommend Favorite

Mesalazine: modified-release superior to standard in UC

By  

Inpharma, Vol. 1, Iss. 1513, 2005-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Modified-release magnesium attenuates premenstrual symptoms

By  

Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Indiplon: Indiplon modified-release, Indiplon MR, NBI 34060, NBI 34060 modified-release, NBI 34060 MR

By  

Drugs in R&D, Vol. 3, Iss. 3, 2002-01 ,pp. : 197-199

Adis International

Access to resources Recommend Favorite